The effect of amino acid deprivation on the transfer of iron through Caco-2 cell monolayers

Journal of Trace Elements in Medicine and Biology

Volumn 40, Issue , 2017, Pages 82-90

  Roussel, Guenievre ^a   Stevens, Valerie ^a   Cottin, Sarah ^a   McArdle, Harry J ^a  

^a ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Amino acid deprivation; Gut transport; Nutrient transfer

Indexed keywords

AMINO ACID; FERRITIN; FERRITIN HEAVY CHAIN; FERROPORTIN; HEPCIDIN; IRON REGULATORY FACTOR; MESSENGER RNA; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; UNCLASSIFIED DRUG; IRON;

AMINO ACID DEFICIENCY; ARTICLE; CACO-2 CELL LINE; CONTROLLED STUDY; EXON; GENE EXPRESSION; IRON METABOLISM; IRON STORAGE; IRON TRANSPORT; PRIORITY JOURNAL; PROTEIN EXPRESSION; CELL MEMBRANE; CYTOLOGY; DEFICIENCY; HUMAN; METABOLISM;

AMINO ACIDS; CACO-2 CELLS; CELL MEMBRANE; HUMANS; IRON;

EID: 85008622697     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2016.12.016     Document Type: Article

References (51)

1. [1] Glahn, R.P., Van Campen, D.R., Iron uptake is enhanced in Caco-2 cell monolayers by cysteine and reduced cysteinyl glycine. J. Nutr. 127 (1997), 642–647.
2. [2] Layrisse, M., Martinez-Torres, C., Leets, I., Taylor, P., Ramirez, J., Effect of histidine, cysteine, glutathione or beef on iron absorption in humans. J. Nutr. 114 (1984), 217–223.
3. [3] Iyengar, V., Pullakhandam, R., Nair, K.M., Dietary ligands as determinants of iron-zinc interactions at the absorptive enterocyte. J. Food Sci. 75 (2010), H260–4.
4. [4] de Silva, D.M., Aust, S.D., Ferritin and ceruloplasmin in oxidative damage: review and recent findings. Can. J. Physiol. Pharmacol. 71 (1993), 715–720.
5. [5] Courselaud, B., Pigeon, C., Inoue, Y., Inoue, J., Gonzalez, F.J., Leroyer, P., et al. C/EBPalpha regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism. Cross-talk between C/EBP pathway and iron metabolism. J. Biol. Chem. 277 (2002), 41163–41170.
6. [6] Dunn, L.L., Rahmanto, Y.S., Richardson, D.R., Iron uptake and metabolism in the new millennium. Trends Cell Biol. 17 (2007), 93–100.
7. [7] Umbreit, J., Iron deficiency: a concise review. Am. J. Hematol. 78 (2005), 225–231.
8. [8] Zimmermann, M.B., Hurrell, R.F., Nutritional iron deficiency. Lancet 370 (2007), 511–520.
9. [9] Shayeghi, M., Latunde-Dada, G.O., Oakhill, J.S., Laftah, A.H., Takeuchi, K., Halliday, N., et al. Identification of an intestinal heme transporter. Cell 122 (2005), 789–801.
10. [10] Khan, A.A., Quigley, J.G., Control of intracellular heme levels: heme transporters and heme oxygenases. Biochim. Biophys. Acta (BBA) - Mol. Cell Res. 1813 (2011), 668–682.
11. [11] West, A.R., Oates, P.S., Mechanisms of heme iron absorption: current questions and controversies. World J. Gastroenterol. 14 (2008), 4101–4110.
12. [12] Ferris, C.D., Jaffrey, S.R., Sawa, A., Takahashi, M., Brady, S.D., Barrow, R.K., et al. Haem oxygenase-1 prevents cell death by regulating cellular iron. Nat. Cell Biol. 1 (1999), 152–157.
13. [13] Munoz, M., Villar, I., Garcia-Erce, J.A., An update on iron physiology. World J. Gastroenterol. 15 (2009), 4617–4626.
14. [14] Kruszewski, M., Labile iron pool: the main determinant of cellular response to oxidative stress. Mutat. Res./Fundam. Mol. Mech. Mutagen. 531 (2003), 81–92.
15. [15] Han, O., Kim, E.Y., Colocalization of ferroportin-1 with hephaestin on the basolateral membrane of human intestinal absorptive cells. J. Cell. Biochem. 101 (2007), 1000–1010.
16. [16] D'Alessio, F., Hentze, M.W., Muckenthaler, M.U., The hemochromatosis proteins HFE, TfR2, and HJV form a membrane-associated protein complex for hepcidin regulation. J. Hepatol. 57 (2012), 1052–1060.
17. [17] Evstatiev, R., Gasche, C., Iron sensing and signalling. Gut 61 (2011), 933–952.
18. [18] Hentze, M.W., Muckenthaler, M.U., Galy, B., Camaschella, C., Two to Tango: regulation of mammalian iron metabolism. Cell 142 (2010), 24–38.
19. [19] Nemeth, E., Tuttle, M.S., Powelson, J., Vaughn, M.B., Donovan, A., Ward, D.M., et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306 (2004), 2090–2093.
20. [20] Hubert, N., Hentze, M.W., Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: implications for regulation and cellular function. Proc. Natl. Acad. Sci. U. S. A. 99 (2002), 12345–12350.
21. [21] Mackenzie, B., Takanaga, H., Hubert, N., Rolfs, A., Hediger, M.A., Functional properties of multiple isoforms of human divalent metal-ion transporter 1 (DMT1). Biochem. J. 403 (2007), 59–69.
22. [22] Tabuchi, M., Tanaka, N., Nishida-Kitayama, J., Ohno, H., Kishi, F., Alternative splicing regulates the subcellular localization of divalent metal transporter 1 isoforms. Mol. Biol. Cell 13 (2002), 4371–4387.
23. [23] Lam-Yuk-Tseung, S., Gros, P., Distinct targeting and recycling properties of two isoforms of the iron transporter DMT1 (NRAMP2, Slc11A2). Biochemistry 45 (2006), 2294–2301.
24. [24] Garrick, M.D., Kuo, H.-C., Vargas, F., Singleton, S., Zhao, L., Smith Jaime, J., et al. Comparison of mammalian cell lines expressing distinct isoforms of divalent metal transporter 1 in a tetracycline-regulated fashion. Biochem. J. 398 (2006), 539–546.
25. [25] Proud, C.G., Control of the translational machinery by amino acids. Am. J. Clin. Nutr. 99 (2014), 231S–236S.
26. [26] Chaveroux, C., Lambert-Langlais, S., Cherasse, Y., Averous, J., Parry, L., Carraro, V., et al. Molecular mechanisms involved in the adaptation to amino acid limitation in mammals. Biochimie 92 (2010), 736–745.
27. [27] Watson, A., Lipina, C., McArdle, H.J., Taylor, P.M., Hundal, H.S., Iron depletion suppresses mTORC1-directed signalling in intestinal Caco-2 cells via induction of REDD1. Cell. Signal. 28 (2016), 412–424.
28. [28] Ferruzza, S., Rossi, C., Scarino, M.L., Sambuy, Y., A protocol for differentiation of human intestinal Caco-2 cells in asymmetric serum-containing medium. Toxicol. In Vitro 26 (2012), 1252–1255.
29. [29] Natoli, M., Leoni, B.D., D'Agnano, I., D'Onofrio, M., Brandi, R., Arisi, I., et al. Cell growing density affects the structural and functional properties of Caco-2 differentiated monolayer. J. Cell. Physiol. 226 (2011), 1531–1543.
30. [30] Briske-Anderson, M.J., Finley, J.W., Newman, S.M., The influence of culture time and passage number on the morphological and physiological development of Caco-2 cells. Proc. Soc. Exp. Biol. Med. 214 (1997), 248–257.
31. [31] Sambuy, Y., De Angelis, I., Ranaldi, G., Scarino, M.L., Stammati, A., Zucco, F., The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol. Toxicol. 21 (2005), 1–26.
32. [32] Ferruzza, S., Rossi, C., Sambuy, Y., Scarino, M.L., Serum-reduced and serum-free media for differentiation of Caco-2 cells. ALTEX 30 (2013), 159–168.
33. [33] Srinivasan, B., Kolli, A.R., Esch, M.B., Abaci, H.E., Shuler, M.L., Hickman, J.J., TEER measurement techniques for In vitro barrier model systems. J. Lab. Autom. 20 (2015), 107–126.
34. [34] Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. NMethods 25 (2001), 402–408.
35. [35] Byrnes, V., Barrett, S., Ryan, E., Kelleher, T., O'Keane, C., Coughlan, B., et al. Increased duodenal DMT-1 expression and unchanged HFE mRNA levels in HFE-associated hereditary hemochromatosis and iron deficiency. Blood Cells. Mol. Dis. 29 (2002), 251–260.
36. [36] Herrmann, T., Muckenthaler, M., van der Hoeven, F., Brennan, K., Gehrke, S., Hubert, N., et al. Iron overload in adult Hfe-deficient mice independent of changes in the steady-state expression of the duodenal iron transporters DMT1 and Ireg1/ferroportin. J. Mol. Med. 82 (2004), 39–48.
37. [37] Ke, Y., Chang, Y.Z., Duan, X.L., Du, J.R., Zhu, L., Wang, K., et al. Age-dependent and iron-independent expression of two mRNA isoforms of divalent metal transporter 1 in rat brain. Neurobiol. Aging 26 (2005), 739–748.
38. [38] Nam, H., Wang, C., Zhang, L., Zhang, W., Hojyo, S., Fukada, T., et al. ZIP14 and DMT1 in the liver, pancreas, and heart are differentially regulated by iron deficiency and overload: implications for tissue iron uptake in iron-related disorders. Haematologica 98 (2013), 1049–1057.
39. [39] Mackenzie, B., Erickson, J.D., Sodium-coupled neutral amino acid (System N/A) transporters of the SLC38 gene family. Pflugers Arch. 447 (2004), 784–795.
40. [40] Frazer, D.M., Anderson, G.J., The orchestration of body iron intake: how and where do enterocytes receive their cues?. Blood Cells Mol. Dis. 30 (2003), 288–297.
41. [41] Kali, A., Charles, M.V.P., Seetharam, R.S.K., Hepcidin - a novel biomarker with changing trends. Pharmacogn. Rev. 9 (2015), 35–40.
42. [42] Darshan, D., Frazer, D.M., Anderson, G.J., Molecular basis of iron-loading disorders. Expert Rev. Mol. Med., 12, 2010, e36.
43. [43] Huang, Y., Li, N., Liboni, K., Neu, J., Glutamine decreases lipopolysaccharide-induced IL-8 production in Caco-2 cells through a non-NF-kappaB p50 mechanism. Cytokine 22 (2003), 77–83.
44. [44] Coeffier, M., Miralles-Barrachina, O., Le Pessot, F., Lalaude, O., Daveau, M., Lavoinne, A., et al. Influence of glutamine on cytokine production by human gut in vitro. Cytokine 13 (2001), 148–154.
45. [45] Linder, M.C., Moriya, M., Whon, A., Kassa, A., Gilley, C., Vesicular transport of Fe and interaction with other metal ions in polarized Caco2 Cell monolayers. Biol. Res. 39 (2006), 143–156.
46. [46] Nunez, M.T., Nunez-Millacura, C., Beltran, M., Tapia, V., Alvarez-Hernandez, X., Apotransferrin and holotransferrin undergo different endocytic cycles in intestinal epithelia (Caco-2) cells. J. Biol. Chem. 272 (1997), 19425–19428.
47. [47] Skjorringe, T., Burkhart, A., Johnsen, K.B., Moos, T., Divalent metal transporter 1 (DMT1) in the brain: implications for a role in iron transport at the blood-brain barrier, and neuronal and glial pathology. Front. Mol. Neurosci., 8, 2015, 19.
48. [48] Ma, Y., Specian, R.D., Yeh, K.-Y., Yeh, M., Rodriguez-Paris, J., Glass, J., The transcytosis of divalent metal transporter 1 and apo-transferrin during iron uptake in intestinal epithelium. Am. J. Physiol. Gastrointest. Liver Physiol. 283 (2002), G965–G974.
49. [49] Moriya, M., Linder, M.C., Vesicular transport and apotransferrin in intestinal iron absorption, as shown in the Caco-2 cell model. Am. J. Physiol. Gastrointest. Liver Physiol. 290 (2006), G301–9.
50. [50] Harrison, M.D., Jones, C.E., Dameron, C.T., Copper chaperones: function, structure and copper-binding properties. J. Biol. Inorg. Chem. 4 (1999), 145–153.
51. [51] Gaetke, L.M., Chow-Johnson, H.S., Chow, C.K., Copper: toxicological relevance and mechanisms. Arch. Toxicol. 88 (2014), 1929–1938.